SAO PAULO, Nov 19 (Reuters) – The first 120,000 doses of CoronaVac, a COVID-19 vaccine developed by China’s Sinovac Biotech that is being tested in Brazil, arrived at Sao Paulo’s international airport on Thursday morning, he said. the state government.
The doses will be stored in an undisclosed warehouse due to the approval of the regulator National Health Surveillance Agency (Anvisa) to use them.
The shipment, which arrived in seven reefer containers, is part of a batch of 6 million doses being imported from China for use in January.
Sao Paulo authorities have not estimated the timing of the distribution. At a press conference in recent days, the government said final phase 3 trials are still underway in Brazil, Indonesia and Turkey to evaluate the efficacy and safety of the vaccine.
Coronavac’s approval will not be completed before December 21 and could take until the first week of January, Anvisa inspections director Ronaldo Gomes told reporters on Wednesday.
A team of Anvisa inspectors is now in Beijing completing a two-week quarantine period at a hotel before they can visit a Sinovac laboratory to certify the vaccine production practices necessary to authorize it in Brazil, he added.
Report by Amanda Perobelli and Eduardo Simões; Written by Sabrina Valle; Edited in Spanish by Ricardo Figueroa